ANNEX III
List of programmes for the monitoring of TSEs as referred to in Article 3(1)
Rate and maximum amount of the Community financial contribution
|
Disease |
Member State |
Rate rapid tests & discriminatory tests performed |
Maximum amount (EUR) |
|
TSEs |
Belgium |
100 % |
2 084 000 |
|
Czech Republic |
100 % |
1 059 000 |
|
|
Denmark |
100 % |
1 680 000 |
|
|
Germany |
100 % |
11 307 000 |
|
|
Estonia |
100 % |
233 000 |
|
|
Greece |
100 % |
1 827 000 |
|
|
Spain |
100 % |
10 237 000 |
|
|
France |
100 % |
24 815 000 |
|
|
Ireland |
100 % |
6 755 000 |
|
|
Italy |
100 % |
3 375 000 |
|
|
Cyprus |
100 % |
348 000 |
|
|
Latvia |
100 % |
312 000 |
|
|
Lithuania |
100 % |
645 000 |
|
|
Luxembourg |
100 % |
146 000 |
|
|
Hungary |
100 % |
784 000 |
|
|
Malta |
100 % |
90 000 |
|
|
Netherlands |
100 % |
5 112 000 |
|
|
Austria |
100 % |
1 759 000 |
|
|
Poland |
100 % |
3 744 000 |
|
|
Portugal |
100 % |
2 115 000 |
|
|
Slovenia |
100 % |
308 000 |
|
|
Slovakia |
100 % |
1 088 000 |
|
|
Finland |
100 % |
839 000 |
|
|
Sweden |
100 % |
2 020 000 |
|
|
United Kingdom |
100 % |
6 781 000 |
|
|
Romania |
100 % |
2 370 000 |
|
|
Total |
91 833 000 |
||
Feedback